154 related articles for article (PubMed ID: 7589901)
1. Conditional inhibition of erythroid differentiation by c-Myb/oestrogen receptor fusion proteins.
Lyon JJ; Watson RJ
Differentiation; 1995 Oct; 59(3):171-8. PubMed ID: 7589901
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
3. c-myb effects on kinetic events during MEL cell differentiation.
Danish R; el-Awar O; Weber BL; Langmore J; Turka LA; Ryan JJ; Clarke MF
Oncogene; 1992 May; 7(5):901-7. PubMed ID: 1533276
[TBL] [Abstract][Full Text] [Related]
4. Deregulated expression of the PU.1 transcription factor blocks murine erythroleukemia cell terminal differentiation.
Rao G; Rekhtman N; Cheng G; Krasikov T; Skoultchi AI
Oncogene; 1997 Jan; 14(1):123-31. PubMed ID: 9010239
[TBL] [Abstract][Full Text] [Related]
5. Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line.
Dmitrovsky E; Kuehl WM; Hollis GF; Kirsch IR; Bender TP; Segal S
Nature; 1986 Aug 21-27; 322(6081):748-50. PubMed ID: 3528861
[TBL] [Abstract][Full Text] [Related]
6. A Myb dependent pathway maintains Friend murine erythroleukemia cells in an immature and proliferating state.
Chen J; Kremer CS; Bender TP
Oncogene; 2002 Mar; 21(12):1859-69. PubMed ID: 11896618
[TBL] [Abstract][Full Text] [Related]
7. Bcl-XL induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization.
Hafid-Medheb K; Poindessous-Jazat V; Augery-Bourget Y; Hanania N; Robert-Lézénès J
Cell Death Differ; 1999 Feb; 6(2):166-74. PubMed ID: 10200563
[TBL] [Abstract][Full Text] [Related]
8. The induction of Friend erythroleukaemia differentiation is markedly affected by expression of a transfected c-myb cDNA.
McMahon J; Howe KM; Watson RJ
Oncogene; 1988 Dec; 3(6):717-20. PubMed ID: 2577875
[TBL] [Abstract][Full Text] [Related]
9. Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation.
Prochownik EV; Kukowska J
Nature; 1986 Aug 28-Sep 3; 322(6082):848-50. PubMed ID: 3528863
[TBL] [Abstract][Full Text] [Related]
10. The role of Ets family transcription factor PU.1 in hematopoietic cell differentiation, proliferation and apoptosis.
Oikawa T; Yamada T; Kihara-Negishi F; Yamamoto H; Kondoh N; Hitomi Y; Hashimoto Y
Cell Death Differ; 1999 Jul; 6(7):599-608. PubMed ID: 10453070
[TBL] [Abstract][Full Text] [Related]
11. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
Pedrazzoli P; Bains MA; Watson R; Fisher J; Hoy TG; Jacobs A
Cancer Res; 1989 Dec; 49(24 Pt 1):6911-6. PubMed ID: 2684403
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2.
Hogg A; Schirm S; Nakagoshi H; Bartley P; Ishii S; Bishop JM; Gonda TJ
Oncogene; 1997 Dec; 15(24):2885-98. PubMed ID: 9416832
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction.
Bauer A; Ulrich E; Andersson M; Beug H; von Lindern M
Oncogene; 1997 Aug; 15(6):701-15. PubMed ID: 9264411
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional activation potential of normal and tumor-associated myb isoforms does not correlate with their ability to block GCSF-induced terminal differentiation of murine myeloid precursor cells.
Patel G; Tantravahi R; Oh IH; Reddy EP
Oncogene; 1996 Sep; 13(6):1197-208. PubMed ID: 8808694
[TBL] [Abstract][Full Text] [Related]
15. Redundant functions of B-Myb and c-Myb in differentiating myeloid cells.
Golay J; Broccoli V; Borleri GM; Erba E; Faretta M; Basilico L; Ying GG; Piccinini G; Shapiro LH; Lovrić J; Nawrath M; Mölling K; Rambaldi A; Introna M
Cell Growth Differ; 1997 Dec; 8(12):1305-16. PubMed ID: 9419419
[TBL] [Abstract][Full Text] [Related]
16. c-Jun inhibits NF-E2 transcriptional activity in association with p18/maf in Friend erythroleukemia cells.
Francastel C; Augery-Bourget Y; Prenant M; Walters M; Martin DI; Robert-Lézénès J
Oncogene; 1997 Feb; 14(7):873-7. PubMed ID: 9047395
[TBL] [Abstract][Full Text] [Related]
17. Multiple mechanisms of regulation of the human c-myb gene during myelomonocytic differentiation.
Boise LH; Gorse KM; Westin EH
Oncogene; 1992 Sep; 7(9):1817-25. PubMed ID: 1323820
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional elongation of c-myb is regulated by NF-kappaB (p50/RelB).
Suhasini M; Pilz RB
Oncogene; 1999 Dec; 18(51):7360-9. PubMed ID: 10602492
[TBL] [Abstract][Full Text] [Related]
19. The carbonic anhydrase I locus contains a c-Myb target promoter and modulates differentiation of murine erythroleukemia cells.
Chen J; Kremer CS; Bender TP
Oncogene; 2006 May; 25(19):2758-72. PubMed ID: 16407849
[TBL] [Abstract][Full Text] [Related]
20. cAMP-induced NF-kappaB (p50/relB) binding to a c-myb intronic enhancer correlates with c-myb up-regulation and inhibition of erythroleukemia cell differentiation.
Suhasini M; Reddy CD; Reddy EP; DiDonato JA; Pilz RB
Oncogene; 1997 Oct; 15(15):1859-70. PubMed ID: 9362453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
